-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Chemours, Lowers Price Target to $18

Benzinga·11/10/2025 17:11:00
Listen to the news
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $21 to $18.